NCT06319300View on ClinicalTrials.gov

Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards

NARecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 19, 2024

Primary Completion Date

March 20, 2026

Study Completion Date

May 20, 2026

Conditions
Diabetes Type 2
Interventions
DEVICE

AI-assisted insulin dose adjustment model

We use an artificial intelligence-assisted insulin dose adjustment system to adjust insulin doses in hospitalised patients

OTHER

doctor's insulin dose adjustment

participants' insulin doses are adjusted by doctors

Trial Locations (1)

200032

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
collaborator

Shanghai Fifth People's Hospital

UNKNOWN

lead

Shanghai Zhongshan Hospital

OTHER